Static Chart Actinogen Medical Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:24 2024-07-12 am EDT			5-day change	1st Jan Change
0.071 ^AUD	-4.05%		+9.23%	+222.73%

Jul. 02	Actinogen Medical Expects Results from XanaCIDD Phase 2a Clinical Trial in August; Shares Down 6%	MT
Jun. 26	Actinogen Medical Limited Announces the Peer-Reviewed Publication of its Phase 2a Biomarker	CI

Duration

Period